Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00818350

Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer

Phase II Study of Sunitinib in Metastatic and Pretreated Urothelial Cancer

Sponsor: Campania Younger Oncologists Association

Interventions SUNITINIB

Updated 5 times since 2017 Last updated: Jan 6, 2009 Started: Jan 31, 2009 Primary completion: Aug 31, 2009 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Urinary Bladder Neoplasms, this trial is ongoing. The trial is conducted by Campania Younger Oncologists Association and has accumulated 5 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Campania Younger Oncologists Association

Data source: Campania Younger Oncologists Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.